Financials
- Market Capitalization 597.02 M
- Employee 40
- Founded 2022
- CEO N/A
- Website www.zurabio.com
- Headquarter Cayman Islands
- FIGI UNKNOWN
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-5.22
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2808 | TECX Tectonic Therapeutic, Inc. - Common Stock | 30.75 USD | +2.77% | -13.79% | +2.81% | +79.30% | 601.14 M USD | ||
| 2811 | VALN Valneva SE - American Depositary Shares | 6.89 USD | -2.41% | +8.50% | +29.51% | -18.56% | 597.84 M USD | ||
| 2815 | AUTL Autolus Therapeutics plc - American Depositary Shares | 2.24 USD | -2.18% | -3.45% | +14.87% | +51.35% | 596.20 M USD | ||
| 2821 | RGNX REGENXBIO Inc. - Common Stock | 8.94 USD | -2.83% | -5.89% | -20.74% | -33.43% | 590.16 M USD |